Ciba-Geigy Moscow purchases SeroStrip tests:
This article was originally published in Clinica
Swiss company Ciba-Geigy's Moscow representative has purchased 3,000 SeroStrip HIV-1/2 tests from Saliva Diagnostic Systems (US). SDS says that the Russian military has also expressed interest in the test. SeroStrip received approval for use and sale within Russia in January this year. Clinical trial evaluation for HemaStrip HIV-1/2, SDS' rapid antibody test, has been completed in Russia and the company expects the product to be registered there shortly.
You may also be interested in...
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.
US FDA will simultaneously review the vaccines, with Moderna’s advisory committee set a week after Pfizer’s. ACIP emergency meeting scheduled for 1 December with vote likely on distribution priority for health care personnel.